Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Velja Mijatovic

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Postmenopause

Chemicals & Drugs

Procedures

Disorders

Cardiovascular Diseases

Concepts & Ideas

Devices

Placebos

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
25
van der Mooren, Marius
21
Kenemans, Peter
11
Vogelvang, Tatjana
7
van Baal, Marchien
6
Netelenbos, Coen
5
Stehouwer, Coen
5
Hompes, Peter
4
Netelenbos, Coen
3
Neele, Simone
3
Peters-Muller, ER
3
Schalkwijk, Casper
3
Jakobs, Cornelis
3
Kamp, Otto
3
de Valk-de Roo, Gerdien
2
Emeis, Jef

Sign-in to see all Coauthors

Publications

TOP 3
Lambers Marieke J; Mijatovic Velja; Hompes Peter G A
Low dose aspirin and IVF: 'Is it time for a meta-analysis'? Continued: the consequences of the choices made.
Medema Titia Jolenta; Dekker Judith J; Mijatovic Velja; van de Velde Wouter J; Schats Roel; Hompes Peter G
A complex malformation of the uterus: report of a tricavitated uterus.
Mijatovic Velja; de Kraker Alyde; van der Vusse Marc; Krebber Anne-Marie
Validity of block randomized clinical trials.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Velja Mijatovic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lambers Marieke J; Mijatovic Velja; Hompes Peter G A
Low dose aspirin and IVF: 'Is it time for a meta-analysis'? Continued: the consequences of the choices made.
Human reproduction update 2009;15(2):262-3.
2008: Medema Titia Jolenta; Dekker Judith J; Mijatovic Velja; van de Velde Wouter J; Schats Roel; Hompes Peter G
A complex malformation of the uterus: report of a tricavitated uterus.
Fertility and sterility 2008;90(5):2012.e7-2012.e11.
2008: Mijatovic Velja; de Kraker Alyde; van der Vusse Marc; Krebber Anne-Marie
Validity of block randomized clinical trials.
Fertility and sterility 2008;89(5):1281; author reply 1281-2.
2008: Tanahatoe Sandra; Lambalk Cornelis; McDonnell Joseph; Dekker Judith; Mijatovic Velja; Hompes Peter
Diagnostic laparoscopy is needed after abnormal hysterosalpingography to prevent over-treatment with IVF.
Reproductive biomedicine online 2008;16(3):410-5.
2007: van Weering H G I; Mijatovic V; Groot J; Hompes P G A; Brölmann H A M
[Pelvic inflammatory disease and an abscessed endometriosis cyst: a diagnostic problem and a therapeutic dilemma]
Nederlands tijdschrift voor geneeskunde 2007;151(13):725-9.
2007: Hompes Peter G A; Mijatovic Velja
Endometriosis: the way forward.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2007;23(1):5-12.
2006: Vogelvang Tatjana Elène; van der Mooren Marius Jan; Mijatovic Velja; Kenemans Peter
Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
Drugs 2006;66(2):191-221.
2005: Vogelvang Tatjana E; Mijatovic Velja; Kenemans Peter; Emeis Jef J; Heijst Johannes A; van der Mooren Marius J
The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: a randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
American journal of obstetrics and gynecology 2005;193(4):1384-94.
2005: Vogelvang T E; Leurs J R; Mijatovic V; Willemse J; van der Mooren M J
HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women.
Journal of thrombosis and haemostasis : JTH 2005;3(5):1090-2.
2005: Vogelvang Tatjana E; Mijatovic Velja; van der Mooren Marius J; Pinsdorf Ursula; von Bergmann Klaus; Netelenbos J Coen; Lütjohann Dieter
Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
Maturitas 2005;50(4):312-20.
2004: Vogelvang Tatjana E; Mijatovic Velja; Kenemans Peter; Teerlink Tom; van der Mooren Marius J
HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women.
Fertility and sterility 2004;82(6):1540-9.
2004: Vogelvang Tatjana E; Mijatovic Velja; Kenemans Peter; Schalkwijk Casper G; van der Mooren Marius J
Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.
The American journal of cardiology 2004;94(9):1205-8.
2004: Vogelvang Tatjana E; Leurs Judith R; van der Mooren Marius J; Mijatovic Velja; Hendriks Dirk F; Neele Simone J M; Netelenbos J Coen; Kenemans Peter
Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women.
Menopause (New York, N.Y.) 2004;11(1):110-5.
2004: Vogelvang Tatjana E; van der Mooren Marius J; Mijatovic Velja
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Treatments in endocrinology 2004;3(2):105-15.
2003: Hemelaar Majoie; van der Mooren Marius J; Mijatovic Velja; Bouman Anneke A; Schijf Charles P T; Kroeks Maurice V A M; Franke Henk R; Kenemans Peter
Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
Menopause (New York, N.Y.) 2003;10(6):550-8.
2003: Vogelvang Tatjana E; van der Mooren Marius J; Kamp Otto; Mijatovic Velja; Visser Cees A; Kenemans Peter
Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function.
Fertility and sterility 2003;80(3):546-53.
2003: Mijatovic Velja; Hompes Peter G A; Wouters Maurice G A J
Familial Mediterranean fever and its implications for fertility and pregnancy.
European journal of obstetrics, gynecology, and reproductive biology 2003;108(2):171-6.
2002: Post M S; van der Mooren M J; Stehouwer C D A; van Baal W M; Mijatovic V; Schalkwijk C G; Kenemans P
Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial.
Thrombosis and haemostasis 2002;88(4):605-10.
2002: Vogelvang Tatjana E; Mijatovic Velja; Kamp Otto; Netelenbos J Coen; Neele Simone J M; Pines Amos; Kenemans Peter; van der Mooren Marius J
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies.
American journal of obstetrics and gynecology 2002;186(4):729-36.
2002: Smolders Raimond G V; Vogelvang Tatjana E; Mijatovic Velja; van Baal W Marchien; Neele Simone J M; Netelenbos J Coen; Kenemans Peter; van der Mooren Marius J
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
Maturitas 2002;41(2):105-14.
2001: Mijatovic V; van der Mooren M J
Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(8):764-7.
2001: Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal W M; Visser C A; van der Mooren M J
Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
American journal of obstetrics and gynecology 2001;184(5):910-6.
1999: de Valk-de Roo G W; Stehouwer C D; Meijer P; Mijatovic V; Kluft C; Kenemans P; Cohen F; Watts S; Netelenbos C
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2993-3000.
1999: Schutter E M; Mijatovic V; Kok A; Van Kamp G J; Verstraeten R; Verheijen R H
Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Anticancer research 1999;19(6C):5551-7.
1999: Mijatovic V; Pines A
The first clinical synthesis conference on hormone replacement therapy: new perspectives for HRT?
Maturitas 1999;33(1):87-92.
1999: Mijatovic V; van der Mooren M J; Stehouwer C D; Netelenbos J C; Kenemans P
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1999;13(2):130-44.
1999: van Baal W M; Kenemans P; Emeis J J; Schalkwijk C G; Mijatovic V; van der Mooren M J; Vischer U M; Stehouwer C D
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
Fertility and sterility 1999;71(4):663-70.
1999: Mijatovic V; van der Mooren M J; Kenemans P; de Valk-de Roo G W; Netelenbos C
Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Menopause (New York, N.Y.) 1999;6(2):134-7.
1998: Mijatovic V; Netelenbos C; van der Mooren M J; de Valk-de Roo G W; Jakobs C; Kenemans P
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women.
Fertility and sterility 1998;70(6):1085-9.
1998: van Ittersum F J; van Baal W M; Kenemans P; Mijatovic V; Donker A J; van der Mooren M J; Stehouwer C D
Ambulatory--not office--blood pressures decline during hormone replacement therapy in healthy postmenopausal women.
American journal of hypertension 1998;11(10):1147-52.
1998: Pines A; Kessel H; Mijatovic V; van der Mooren M J
Hormone replacement therapy and cardioprotection in the elderly.
Journal of the Royal Society of Medicine 1998;91(9):475-8.
1998: van der Mooren M J; Mijatovic V; van Baal W M; Stehouwer C D
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.
Maturitas 1998;30(1):27-36.
1998: Mijatovic V; Kenemans P; Netelenbos C; Jakobs C; Popp-Snijders C; Peters-Muller E R; van der Mooren M J
Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.
Fertility and sterility 1998;69(5):876-82.
1998: Mijatovic V; Kenemans P; Jakobs C; van Baal W M; Peters-Muller E R; van der Mooren M J
A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.
Obstetrics and gynecology 1998;91(3):432-6.
1997: Mijatovic V; Kenemans P; Netelenbos J C; Peters-Muller E R; van Kamp G J; Voetberg G A; van de Weijer P H; van der Mooren M J
Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.
The Journal of clinical endocrinology and metabolism 1997;82(11):3543-7.
1997: Pines A; Mijatovic V; van der Mooren M J; Kenemans P
Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations.
European journal of obstetrics, gynecology, and reproductive biology 1997;71(2):193-7.

Sign-in to see more